AKT1 and breast neoplasm: Finally, Pep2–Ae enhanced the activity of AKT1 and FOXO1, and reduced the expression of FOXO1 and SOX2 in MMTV-PyMT MEC-derived breast tumors and PDX-derived breast tumors (Fig. 8f).